![Benjamin Weinberg, MD, FACP Profile](https://pbs.twimg.com/profile_images/1797386037531918336/sA146qdE_x96.jpg)
Benjamin Weinberg, MD, FACP
@benweinbergmd
Followers
3K
Following
10K
Statuses
2K
GI Cancers Disease Group Leader | Assoc Prof of Med @Georgetown @RueschCenter @LombardiCancer, Ex-@SidwellFriends @Penn @KeckMedUSC | keyboardist @BasementRiot
Washington, DC
Joined October 2012
Thrilled to announce our new publication: "Rethinking the Rise of Early Onset GI Cancers" @JNCI_Now Spectrum @RueschCenter @marshalj23 @priyanka_kanth @ReetuMukherjiMD @MarionHartley4 @annebchin @CancerMicrobes @BlaesAnneMD @NancyYouMD @GiannakisLab
1
13
45
RT @aberkenblit: Exciting news in precision medicine! Zenocutuzumab clinical trial results are published in @NEJM, showing strong responses…
0
8
0
RT @RueschCenter: This week, we highlighted exciting research by @AliSchram, @MacarullaTeresa, @AHollebecque, @EileenMOReilly, @oncoOuLungC…
0
1
0
RT @oncodaily: Efficacy of Zenocutuzumab in NRG1 Fusion-Positive Cancer - @benweinbergmd
@NEJM @AliSchram @Stephe…
0
5
0
Congrats @claudine_isaacs and all the new FASCOs!
Join us in congratulating the following members on earning the Fellows of ASCO (FASCO) distinction last quarter! We are grateful for their extraordinary volunteer service, dedication, and commitment to ASCO. Learn more:
0
2
5
RT @ArndtVogel: Combined Analyses of ctDNA &Immunoscore in Stage III Colon Cancer 🔎Post Hoc of te PRODIGE-GERCOR IDEA-France/ HORG-IDEA-Gre…
0
13
0
RT @StephenVLiu: Results from the phase II study of zenocutuzumab in #NRG1 fusion+ cancers now @NEJM. RR 30% with DOR 11.1m, PFS 6.8m, fav…
0
27
0
RT @NEJM: A basket study evaluated the efficacy of zenocutuzumab, a bispecific antibody against HER2 and HER3, in patients with solid tumor…
0
46
0
Paper is out!!! FDA approved for NRG1 Fusion+ Non-Small Cell #LungCancer and #PancreaticCancer Efficacy of Zenocutuzumab in NRG1 Fusion–Positive Cancer @AliSchram @StephenVLiu @GIcancerDoc @KReissMD @MerusNV @NEJM @MSKCancerCenter @LombardiCancer
6
26
95
RT @RueschCenter: Join us to review exciting @ASCO #GI25 meeting research. @marshalj23, @benweinbergmd, @RuthHe12, @ReetuMukherjiMD will hi…
0
2
0
RT @GiOncNow: 📺 We spoke with @benweinbergmd while at @ASCO #GI25 on new data from CheckMate 9DW, 8HW, NEST, and more. 👉 Catch up with so…
0
3
0
RT @RueschCenter: CheckMate 9DW, 8HW, NEST, and Bot/Bal. @benweinbergmd @LombardiCancer shares his perspective from @ASCO #GI125. https://t…
0
3
0
RT @RueschCenter: We recently highlighted research by Purvi Jonnalagadda, Virginia Arnold, and @benweinbergmd in @JournalGICancer @Spring…
0
1
0
RT @RueschCenter: “Investigating the clinical and molecular characteristics of class II and III BRAF mutations and their response to anti-…
0
6
0